Table 3 The odds ratio of compliance six months after the implementation of clinical guidelines for the management of suicidal patients.
From: An approach to measure compliance to clinical guidelines in psychiatric care
Implementation clinics | Control clinics | |
|---|---|---|
Indicator | OR(CI95%) | OR(CI95%) |
Accessibility/wait time | 0.9(0.4–1.8) | 1.1(0.5–2.4) |
Diagnostic assessment | 2.8(1.6–4.8) | 0.6(0.2–1.5) |
Diagnostic instrument | * | * |
Standardized rating scale | 2.9(1.7–4.9) | 0.5(0.2–1.4) |
Standardized rating scale during treatment | 6.0(3.3–11.2) | 0.6(0.2–1.9) |
Substance/drug abuse | 1.7(1.0–2.8) | 1.0(0.5–2.2) |
Treatment (care) plan | 4.6(2.6–8.1) | 0.9(0.4–2.0) |
Evaluation/outcome | 3.5(2.0–6.2) | 0.4(0.1–1.2) |
Continuity | 0.7(0.4–1.5) | 0.5(0.2–1.0) |
Suicide assessment | 11.5(5.1–25.8) | 0.6(0.3–1.5) |
Specialist assessment | 6.6(3.5–12.6) | 0.8(0.3–2.3) |
Follow-up | 2.9(1.4–5.7) | 0.6(0.3–1.4) |
Evaluation assessment | 3.9(2.2–6.4) | 0.7(0.3–1.8) |
t-value, p-value | t-value, p-value | |
Total score | 9.0, 0.001 | -2.1, 0.1 |